Tags : Mubadala Investment

Series D

Exscientia secures £162 million Series D investment led by SoftBank

Exscientia announces investment of up to $525M Proceeds to continue expansion of proprietary pipeline and end-to-end AI drug discovery capabilities $225 million Series D round closed with access up to an additional $300 million at Exscientia’s discretion Financing led by SoftBank Vision Fund 2 27th April, 2021, Oxford, UK – Exscientia, a clinical stage pharmatech company using […]Read More


MEL Science secures 10.5 million Series B investment led by

MEL Science secures $14M in Series B funding to expand award-winning at-home science education offering  LONDON, 01 December, 2020 – MEL Science, a London-based science educational platform, today announces that it has secured $14 million in Series B funding to support demand for its subscription-based offering. International investors include Mubadala Investment Company, Channel 4 Ventures […]Read More